Universitaetsklinikum Regensburg AöR

Clinical research includes metastatic melanoma, with attention to treatment strategies used after disease stabilization on PD-1 inhibitor therapy. The sponsor’s oncology portfolio also extends to advanced solid tumours involving the central nervous system.

• Metastatic melanoma
• PD-1 inhibitor therapy
• Central nervous system involvement

Research activity in this area reflects interest in immuno-oncology and in treatment approaches for difficult-to-manage metastatic disease.